Susanne M.
- Country
- Sweden
- Department
- Department of Oncology
Research Overview
- Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine or Investigator's Choice Chemotherapy in Patients with FRα-High or FRα-Low Platinum-Resistant Epithelial Ovarian Cancer
- Evaluation of Olaparib, Durvalumab, and UV1 as Maintenance Therapy in BRCA Wild-Type Recurrent Ovarian Cancer: A Randomized Clinical Trial
- Phase 3 Study of Rucaparib and Nivolumab as Maintenance Therapy in Advanced High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Data & Insights
Has run more than one trial at 99 of 223 partner sites.
Specializations
Gynecologic Oncology
This investigator specializes in treating complex gynecologic cancers, with particular emphasis on epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
- Advanced Stage Cancers
- Recurrent Disease Management
- High-grade Malignancies
The investigator focuses on cases requiring specialized treatment approaches for both newly diagnosed and relapsed conditions.
Therapeutic Innovation
Expertise in implementing novel therapeutic strategies, including maintenance therapy and combination treatment approaches for gynecologic cancers.
- Targeted Therapies
- Immunotherapy Applications
- Platinum-based Treatment
Specialized interest in developing personalized treatment strategies for patients with varying response patterns to standard therapies.
Treatment Response Assessment
Focused on evaluating patient responses to various therapeutic interventions using advanced assessment criteria and monitoring protocols.
- Treatment Efficacy Evaluation
- Safety Assessment
- Response Monitoring
Particular attention to determining optimal dosing strategies and therapeutic combinations for enhanced patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.